HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Screening Utility of the King-Devick Test in Mild Cognitive Impairment and Alzheimer Disease Dementia.

Abstract
The King-Devick (K-D) test is a 1 to 2 minute, rapid number naming test, often used to assist with detection of concussion, but also has clinical utility in other neurological conditions (eg, Parkinson disease). The K-D involves saccadic eye and other eye movements, and abnormalities thereof may be an early indicator of Alzheimer disease (AD)-associated cognitive impairment. No study has tested the utility of the K-D in AD and we sought to do so. The sample included 206 [135 controls, 39 mild cognitive impairment (MCI), and 32 AD dementia] consecutive subjects from the Boston University Alzheimer's Disease Center registry undergoing their initial annual evaluation between March 2013 and July 2015. The K-D was administered during this period. Areas under the receiver operating characteristic curves generated from logistic regression models revealed the K-D test distinguished controls from subjects with cognitive impairment (MCI and AD dementia) [area under the curve (AUC)=0.72], MCI (AUC=0.71) and AD dementia (AUC=0.74). K-D time scores between 48 and 52 seconds were associated with high sensitivity (>90.0%) and negative predictive values (>85.0%) for each diagnostic group. The K-D correlated strongly with validated attention, processing speed, and visual scanning tests. The K-D test may be a rapid and simple effective screening tool to detect cognitive impairment associated with AD.
AuthorsKristin M Galetta, Kimberly R Chapman, Maritza D Essis, Michael L Alosco, Danielle Gillard, Eric Steinberg, Diane Dixon, Brett Martin, Christine E Chaisson, Neil W Kowall, Yorghos Tripodis, Laura J Balcer, Robert A Stern
JournalAlzheimer disease and associated disorders (Alzheimer Dis Assoc Disord) 2017 Apr-Jun Vol. 31 Issue 2 Pg. 152-158 ISSN: 1546-4156 [Electronic] United States
PMID27299935 (Publication Type: Journal Article)
Topics
  • Aged
  • Alzheimer Disease (diagnosis)
  • Cognitive Dysfunction (diagnosis)
  • Female
  • Humans
  • Male
  • Neuropsychological Tests (statistics & numerical data)
  • Saccades (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: